November 18, 2026
Health news, explained with evidence
LIVE

New Machine Learning Model Identifies Patients at Risk for Prolonged Influenza A Positivity

❤️ Conditions & Care 1 min read 👁 4

Researchers have developed an interpretable machine learning tool designed to identify hospitalized adults at risk for persistent influenza A positivity after standard antiviral treatment.

❤️Conditions & Care

Key points

  • New machine-learning model predicts persistent influenza A positivity
  • XGBoost algorithm showed strong predictive performance in validation tests
  • C-reactive protein and lymphocyte counts were key predictors

A team of researchers has created an interpretable machine-learning model capable of predicting which hospitalized patients with influenza A will remain nucleic-acid positive following a standard course of antiviral therapy. While many patients recover fully, a notable proportion continues to test positive, presenting ongoing clinical challenges when reliable predictive tools are absent at admission.

The retrospective study analyzed 432 hospitalized adults with laboratory-confirmed influenza A, splitting them into training and validation cohorts. Out of several algorithms evaluated, the XGBoost model demonstrated the strongest predictive performance, achieving a validation area under the curve of 0.835. Using SHAP-based interpretability, the researchers found that C-reactive protein levels served as the primary predictor, followed by lymphocyte count, patient age, vomiting symptoms, aspartate aminotransferase, blood urea, and pre-existing kidney disease.

What to know: Persistent viral positivity occurred in roughly 29% of both cohorts in this retrospective study. Because the tool is still in its early stages of development, further external validation and prospective evaluation are required before it can be integrated into routine clinical workflows. Readers should consult a qualified healthcare provider for any personal medical decisions regarding influenza or antiviral treatments.

Source Nature Health Sciences — nature.com/articles/s41598-026-80585-z ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.